Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03373877 |
Title | Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of Myelofibrosis |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Samus Therapeutics, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Yale Cancer Center | New Haven | Connecticut | 06511 | United States | Details | |
Ochsner Clinic Foundation | New Orleans | Louisiana | 70121 | United States | Details | |
University of Michigan | Ann Arbor | Michigan | 48109 | United States | Details | |
Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
University of Nebraska Medical Center | Omaha | Nebraska | 68198 | United States | Details | |
Duke University Medical Center | Durham | North Carolina | 27710 | United States | Details | |
Cleveland Clinic - Taussig Cancer Institute | Cleveland | Ohio | 44195 | United States | Details | |
Abramson Cancer Center - University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Mays Cancer Center UT Health San Antonio | San Antonio | Texas | 78229-3900 | United States | Details |